🧬 BDNF Extraction Viewer

Извлечено: 997 / 997 (100.0%) Средняя confidence: 0.13
← Назад к списку

p-Synephrine, synergistically with Gastrodin, alleviates reserpine-induced depressive pathologies by binding to MT

PMID: 41505914 · DOI: 10.1016/j.phymed.2025.157757 · Phytomedicine : international journal of phytotherapy and phytopharmacology, 2026 · Hong-Lei Gao, Huan Chen, Xiao-Yan Zhang, Tian-Rui Xu, Xiao-Xi Guo
📄 Abstract

p-Synephrine (p-Syn), a natural alkaloid isolated from Citrus aurantium L., promotes fat oxidation and is therefore widely used as a weight loss dietary supplement. It was recently reported to exert a potent antidepressant effect. However, its molecular targets remain undefined. Gastrodin (Gas), extracted from Gastrodia elata Blume, exerts antidepressant effects by targeting Melatonin Receptor 1A (MT This study aimed to evaluate whether MT Network pharmacology was applied to predict potential targets and associated signaling pathways for p-Syn and Gas. Molecular Docking simulations were employed to predict the possible binding sites of MT Using a network pharmacology approach and in vitro assays, we found that both p-Syn and Gas bind to MT1, activate the ERK/CREB signaling pathway, and up-regulate BDNF. In vivo assays showed that p-Syn alleviated Reserpine (Res)-induced depression-like symptoms in AB zebrafish larvae and C57 mice. Furthermore, p-Syn and Gas showed a remarkable synergistic effect. This study identifies a novel target for p-Syn and provides new insights into the antidepressant mechanisms of p-Syn and Gas that may contribute to the clinical application of these compounds in the development of new drugs for the treatment of depression.

Confidence: 0.39 · 21 полей извлечено
Идентификация (6 полей)
Target
MT1
0.90
Alt. target
Melatonin Receptor 1A
0.90
Protein family
G protein-coupled receptor
0.80
Functional class
Receptor
0.80
Subcellular loc.
Plasma membrane
0.70
Isoforms (metab/obesity)
0.00
Механизм действия (21 полей)
Mechanism
Binds to MT1 receptor, activates ERK/CREB signaling pathway, up-regulates BDNF
0.90
Mutations (obesity/lean)
0.00
Activity (obesity)
Promotes fat oxidation; used as a weight loss dietary supplement
0.80
Activity temporal
0.00
Energy balance
Promotes fat oxidation, suggesting a role in increasing energy expenditure
0.70
Appetite
0.00
Fat metabolism
Promotes fat oxidation
0.90
Lipolysis
0.00
Thermogenesis
0.00
Muscle metabolism
0.00
Inflammation
0.00
Glucose metabolism
0.00
AA metabolism
0.00
Hormonal pathways
Binds to MT1 receptor, which is involved in melatonin signaling
0.80
Cell death
0.00
Adipocyte fibrosis
0.00
Upstream (biochem)
0.00
Upstream (physiol)
0.00
Downstream (biochem)
ERK/CREB signaling pathway, BDNF
0.90
Downstream (physiol)
Alleviation of depressive symptoms
0.80
PTMs
0.00
Экспрессия (8 полей)
Tissue expression
0.00
In vitro
in vitro assays
0.90
In vivo
AB zebrafish larvae and C57 mice
0.95
In silico
network pharmacology approach, molecular docking simulations
0.95
Genetic association
0.00
Ex vivo
0.00
Animal model
AB zebrafish larvae, C57 mice
0.95
Diet/model
reserpine-induced depression model
0.90
Клиника (11 полей)
Drug
p-Synephrine
0.95
Indication
depression
0.90
Patient subgroups
0.00
Safety concerns
0.00
Off-target
0.00
Trial stage
0.00
Pharma competitors
0.00
AE severity
0.00
MOA weight loss
promotes fat oxidation
0.90
Endpoints
0.00
Approved
False
0.80